Recent advances in radiotherapy of breast cancer-Reference-Cited by-同舟云学术

Recent advances in radiotherapy of breast cancer

Published:2020-03-30 Issue:1 Volume:15 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Haussmann Jan,Corradini Stefanie,Nestle-Kraemling Carolin,Bölke Edwin,Njanang Freddy Joel Djiepmo,Tamaskovics Bálint,Orth Klaus,Ruckhaeberle Eugen,Fehm Tanja,Mohrmann Svjetlana,Simiantonakis Ioannis,Budach Wilfried,Matuschek Christiane

Abstract

AbstractRadiation therapy is an integral part of the multidisciplinary management of breast cancer. Regional lymph node irradiation in younger trials seems to provide superior target coverage as well as a reduction in long-term toxicity resulting in a small benefit in the overall survival rate. For partial breast irradiation there are now two large trials available which support the role of partial breast irradiation in low risk breast cancer patients. Multiple randomized trials have established that a sequentially applied dose to the tumor bed improves local control with the cost of worse cosmetic results.

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-020-01501-x.pdf

Reference59 articles.

1. Schonecker S, Walter F, Freislederer P, et al. Treatment planning and evaluation of gated radiotherapy in left-sided breast cancer patients using the catalyst(TM)/sentinel(TM) system for deep inspiration breath-hold (DIBH). Radiat Oncol. 2016;11:143.

2. Trivedi SJ, Choudhary P, Lo Q, et al. Persistent reduction in global longitudinal strain in the longer term after radiation therapy in patients with breast cancer. Radiother Oncol. 2019;132:148–54.

3. Simonetto C, Eidemuller M, Gaasch A, et al. Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy. Radiother Oncol. 2019;131:202–7.

4. Kaidar-Person O, Offersen BV, Poortmans P. Should risk-adapted delineation considered de-escalation of therapy? The ESTRO-ACROP radiation therapy guidelines after implant-based immediate reconstruction for early stage breast cancer. Radiother Oncol. 2019;141:327–28. https://doi.org/10.1016/j.radonc.2019.07.032.

5. Cai G, Cao L, Kirova YM, Feng Y, Chen JY. Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer. Radiat Oncol. 2019;14:115.

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting DNA damage repair mechanism by using RAD50-silencing siRNA nanoparticles to enhance radiotherapy in triple negative breast cancer;Materials Today Bio;2024-10

2. Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review;Journal of Drug Delivery Science and Technology;2024-10

3. Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment;Cancer Drug Resistance;2024-09-13

4. Applicability of Quantum Dots in Breast Cancer Diagnostic and Therapeutic Modalities—A State-of-the-Art Review;Nanomaterials;2024-08-31

5. Does Sentinel Lymph Node Biopsy Influence Subsequent Management Decisions in Women With Breast Cancer ≥ 70 Years Old?;Clinical Breast Cancer;2024-08